Search Results for: rewalk

[ReWalk in GlobeNewsWire] ReWalk Robotics to acquire AlterG; acquisition builds commercial scale and accelerates path to profitability

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Aug. 08, 2023 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced the execution of a definitive agreement to acquire AlterG, Inc. (“AlterG”), a leading innovator and provider of Anti-Gravity systems for use in physical and neurological rehabilitation. This transaction adds AlterG’s current and future product lines to ReWalk’s existing portfolio of neurorehabilitation products and is expected to substantially expand its customer-facing capabilities and advance future growth opportunities. Read more...

Read More

[ReWalk in GlobeNewsWire] ReWalk Robotics announces planned changes to board of directors

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, July 28, 2023 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced that two members of the Board of Directors (the “Board”), Arik Dan and Wayne Weisman, have indicated that they do not plan to seek re-election when their terms expire at the next Annual Meeting of Shareholders.   The Company does not expect to nominate any replacement candidates, and these retirements consequently will reduce the size of the Board from ten to eight directors. Read more...

Read More

[ReWalk in GlobeNewsWire] ReWalk Robotics applauds medicare proposal to include personal exoskeletons in a medicare benefit category to be paid on a lump sum basis

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 30, 2023 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or “the Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, applauds the Centers for Medicare & Medicaid Services (“CMS”) proposal to include personal exoskeletons in the Medicare benefit category for braces. CMS issued the proposal as part of the Calendar Year 2024 Home Health Prospective Payment System Proposed Rule, CMS-1780 (Proposed Rule), released on June 30, 2023. Read more...

Read More

[ReWalk in GlobeNewswire] Advancement in ReWalk technology achieves FDA clearance as only personal exoskeleton to enable use on stairs and curbs

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, March 07, 2023 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd., (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, announced today that its innovative ReWalk Personal Exoskeleton technology has received clearance from the Food and Drug Administration (“FDA”) for use on stairs and curbs in the United States, making it the only personal exoskeleton to receive FDA clearance for this indication. Read more...

Read More